In Figure 3, the fluorescence images show that IR700Dye and Alexa488 from the HER2 Affibody-IR700Dye conjugate and the trastuzumab-Alexa488 conjugate clearly merged in the HER2-positive cancer cells. This evidence concerns the gene ERBB2 and cancer.